Dow Jones

38 711,29

0,00%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Canadá
TSX
Bausch Health Companies Inc (BHC)
Bausch Health Companies Inc (BHC) Actualités

BHC

Bausch Health Companies (BHC)

Bausch Health Companies Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:TSX:BHC

1 2 3 4 5 6 7 8 9 10 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
11/04/2024	17h17	PR Newswire (Canada)	L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - BHC	TSX:BHC	Bausch Health Companies Inc
11/04/2024	17h17	PR Newswire (Canada)	Canadian Investment Regulatory Organization Trade Resumption - BHC	TSX:BHC	Bausch Health Companies Inc
11/04/2024	17h08	PR Newswire (Canada)	Suspension de la négociation par l'Organisme canadien de réglementation des investissements - BHC	TSX:BHC	Bausch Health Companies Inc
11/04/2024	17h03	PR Newswire (Canada)	Canadian Investment Regulatory Organization Trading Halt - BHC	TSX:BHC	Bausch Health Companies Inc
31/05/2023	14h00	PR Newswire (US)	OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease	TSX:BHC	Bausch Health Companies Inc
17/05/2023	19h34	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - BHC	TSX:BHC	Bausch Health Companies Inc
17/05/2023	19h33	PR Newswire (Canada)	IIROC Trade Resumption - BHC	TSX:BHC	Bausch Health Companies Inc
17/05/2023	19h18	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - BHC	TSX:BHC	Bausch Health Companies Inc
17/05/2023	19h17	PR Newswire (Canada)	IIROC Trading Halt - BHC	TSX:BHC	Bausch Health Companies Inc
17/05/2023	18h43	PR Newswire (Canada)	ttIIROC Trading Halt - BHC	TSX:BHC	Bausch Health Companies Inc
03/05/2023	12h58	PR Newswire (Canada)	RYALTRIS®, a new combination prescription nasal spray for moderate to severe seasonal allergic rhinitis (SAR), now available across Canada	TSX:BHC	Bausch Health Companies Inc
03/05/2023	12h58	PR Newswire (Canada)	RYALTRIS(MD), une nouvelle association sous ordonnance en pulvérisateur nasal pour la rhinite allergique saisonnière (RAS) d'intensité modérée à grave, est maintenant disponible partout au Canada	TSX:BHC	Bausch Health Companies Inc
22/12/2022	12h59	PR Newswire (Canada)	First tazarotene lotion treatment for acne vulgaris, ARAZLO™ (tazarotene lotion, 0.045%), now available to patients through Quebec, Ontario, Alberta, Saskatchewan and federal NIHB public drug plans	TSX:BHC	Bausch Health Companies Inc
22/12/2022	12h59	PR Newswire (Canada)	ARAZLOMC (lotion de tazarotène, 0,045 %), la première lotion à base de tazarotène indiquée pour le traitement de l'acné vulgaire, est maintenant offerte aux patients du Québec, de l'Ontario, de l'Alberta et de la Saskatchewan dans le cadre des régi	TSX:BHC	Bausch Health Companies Inc
12/10/2022	14h00	PR Newswire (Canada)	SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION	TSX:BHC	Bausch Health Companies Inc
05/10/2022	14h00	PR Newswire (US)	Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022	TSX:BHC	Bausch Health Companies Inc
03/10/2022	14h00	PR Newswire (US)	SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY	TSX:BHC	Bausch Health Companies Inc
28/09/2022	14h09	PR Newswire (US)	Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations	TSX:BHC	Bausch Health Companies Inc
23/09/2022	12h59	PR Newswire (Canada)	Bausch Health and Glenmark Announce the approval of RYALTRIS® in Canada	TSX:BHC	Bausch Health Companies Inc
23/09/2022	12h59	PR Newswire (Canada)	Bausch Health et Glenmark annoncent l'approbation du RYALTRIS MD au Canada	TSX:BHC	Bausch Health Companies Inc
14/09/2022	15h00	PR Newswire (US)	Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations	TSX:BHC	Bausch Health Companies Inc
09/09/2022	13h00	PR Newswire (Canada)	Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin	TSX:BHC	Bausch Health Companies Inc
08/09/2022	22h45	PR Newswire (US)	Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations	TSX:BHC	Bausch Health Companies Inc
03/09/2022	00h27	PR Newswire (Canada)	S&P Dow Jones Indices annonce des modifications à l'indice composé S&P/TSX et à l'indice S&P/TSX 60	TSX:BHC	Bausch Health Companies Inc
02/09/2022	23h15	PR Newswire (Canada)	S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index and S&P/TSX 60 Index	TSX:BHC	Bausch Health Companies Inc
31/08/2022	05h28	PR Newswire (US)	Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes	TSX:BHC	Bausch Health Companies Inc
22/08/2022	13h00	PR Newswire (US)	Bausch Health Continuing Process Toward Separating Bausch + Lomb	TSX:BHC	Bausch Health Companies Inc
11/08/2022	00h00	PR Newswire (Canada)	Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit	TSX:BHC	Bausch Health Companies Inc
10/08/2022	13h00	PR Newswire (US)	Salix Supports CMS Announcement of First ICD-10 Code for Hepatic Encephalopathy (HE)	TSX:BHC	Bausch Health Companies Inc
09/08/2022	13h00	PR Newswire (Canada)	BAUSCH HEALTH ANNOUNCES SECOND-QUARTER 2022 RESULTS	TSX:BHC	Bausch Health Companies Inc